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patients (in 2003, Micali et al. [3] calculated 
19 patients in the literature; afterwards, just 
a few isolated case reports were published).
In 1994, Chang and colleagues discovered 
the association between KS and infection of 
neoplastic cells by human herpes virus type 8 
(HHV-8) [4]. This virus belongs to the fam-
ily of gamma-herpesviruses and its role as 
a potential oncogenic virus is supported by 
its tight relationship with primary effusion 
lymphoma (PEL). The genome of this virus 
was shown to be present in about 90% of 
HIV-positive patients with KS. This implies 
a role in the etiology of Kaposi’s sarcoma.
IntroduCtIon
Kaposi’s sarcoma (KS) is a lesion of vas-
cular origin, known since the 19th century. 
To date, four different clinical forms have 
been identified [1]:
 y the classic, which is typical in Mediter-
ranean countries and the central regions 
of Africa;
 y the lymphoadenopathic, a form that oc-
curs in young African children;
 y the transplantation-associated, particu-
larly affecting patients who underwent 
kidney transplantation;
 y the AIDS-related.
Kaposi’s sarcoma affects primarily the 
skin, but it may also be detected in the vis-
ceral mucosa, even if it is rarely located on 
the glans penis (37 cases found in the litera-
ture, according to Rescigno and colleagues 
[2]), sometimes involving HIV-negative 
Why Do we Describe These Cases
Penile Kaposi’s sarcoma is an uncommon 
disease with a very difficult histopatho-
logical diagnosis. To date, the most effec-
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Abstract
Kaposi’s sarcoma (KS) is a rare tumor of vascular origin. It is quite common in HIV patients. 
It is rarely located on the glans penis, especially in HIV-negative patients (just some tens in the 
literature). Owing to the rarity of the disease, both the real impact on survival and the most 
suitable therapy are not known.
However, in this 3-patient case series, carbon dioxide laser therapy was effective both for local 
control and survival. In fact, two late relapses but no disease-related death were recorded. 
Probably, KS in HIV-negative patients is a slowly progressive disease, not so aggressive as in 
HIV-positive patients. Laser therapy is easy, fast, and cheap, and may treat the disease radically.
If these data are confirmed by further studies, in the foreseeable future, laser therapy may become 
the gold standard for treating HIV-negative patients affected by penile KS. 
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We report three cases involving HIV-
negative patients with lesions on the mucosa 
of glans penis and penile shaft. Tumor cells 
were infected by HHV-8.
CASeS deSCrIPtIon
In our patients, we recorded main dis-
eases and the medical history linked to the 
penile lesions. Moreover, we analyzed their 
immune status (particularly, testing for HIV 
virus) and photos of the lesions were taken 
before and after surgery. Chest and abdo-
men CT scans were performed before sur-
gery and after 12 and 24 months. Moreover, 
outpatient examinations were performed 
every six months for at least five years. An 
inguinal ultrasound was performed during 
examinations.
Case 1
S.G. was 60 years old, came from Sicily, 
and underwent a surgical excision of a small 
lesion of the glans in September 2013 in an-
other hospital. He was diagnosed with KS, 
but no test for HHV-8 was performed. No 
major disease was recorded.
In November 2016, he came to the Uro-
logic Unit of our Institute for a mucosal 
lesion of the dorsal glans. The lesion was 
radically excised by carbon dioxide laser and 
he was diagnosed with Kaposi’s sarcoma as-
sociated HHV-8. HIV tests were negative.
In May 2017, another lesion of the dorsal 
glans was excised and the diagnosis was the 
same. Before and after surgery, the disease 
staging by CT scan was negative and at pres-
ent the patient is disease-free.
Case 2
Z.O. was 71 years old, came from Sic-
ily, and underwent a surgical excision of a 
perimeatal lesion of the glans in July 2013 
in another hospital. The surgical excision was 
performed during a transurethral resection 
of prostate (TURP) for benign prostatic 
hyperplasia. No other major disease was re-
corded. Also in this patient the diagnosis was 
KS but no test for HHV-8 was performed. 
HIV test was negative.
In May 2014, he was examined in the 
Urologic Unit of our Institute for a small 
and bluish lesion of the dorsal penile cutis 
(Figure 1), that was radically excised by car-
bon dioxide laser. The diagnosis was Kaposi’s 
sarcoma associated HHV-8.
In July 2015, a small preputial lesion (his-
tological relapse of KS) was laser excised. 
Before and after surgery, no systemic disease 
was found at CT scan and at present the 
patient is disease-free.
Case 3
N.F. was 77 years old, came from Apulia, 
and was examined in our Urologic Unit for 
plurifocal nodular and reddish lesions of the 
glans and the prepuce (Figure 2) in July 2014.
He was suffering from diabetes type 2, 
mild hypertension, and obesity. The lesions 
Figure 1. Small and 
bluish lesion of the 
dorsal penile cutis before 
carbon dioxide laser 
excision (case 2)
Figure 2. Plurifocal 
nodular and reddish 
lesions in the glans 
and the prepuce before 
carbon dioxide laser 
excision and surgical 
circumcision (case 3)
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were radically excised by carbon dioxide laser 
and surgical circumcision. In every specimen, 
KS-associated HHV-8 was found. Before 
surgery, HIV test and CT scan were nega-
tive. After surgery, CT scans did not show 
any systemic disease.
After two years, reddish papules of the 
perimalleolar skin were found (Figure 3), 
but they were not removed because the pa-
tient suddenly died from stroke. No local 
relapse was found.
Main surgical aspects
All the lesions on the glans penis and 
penile shaft were locally anesthetized with 
2% lidocaine after the local application of 
anesthetizing gel (EMLA). Ablation was 
done with a high-energy pulsed carbon 
dioxide laser at a power of 10 watts with a 
4-mm spot size (SHARPLAN 40 C CO2 
40 Watt, 10600 nm, KOSMO). There was 
very little bleeding during the treatment and 
the lesions healed rapidly in a few days with 
topical antibacterial (gentamicin) ointment 
application, leaving good cosmetic results 
(Figure 4).
Immunohistochemical analysis
The biopsy specimen was routinely fixed 
in formalin (10%), embedded in paraffin and 
then cut at 4 µm and stained with hematox-
Figure 3. Reddish 
papules of the 
perimalleolar skin 
found two years after 
carbon dioxide laser 
excision of the lesions in 
the glans and surgical 
circumcision (case 3)
Figure 4. Cosmetic 
results two years after 
treatment (case 1)
ylin-eosin. The immunohistochemical stud-
ies were performed on paraffin tissue sec-
tions of the lesion using antibodies against 
CD34 and factor VIII-related antigen 
(HHV-8, clone LN53, Novus; DAKO au-
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tostainer). Histologically, lesions were nod-
ules in the lamina propria, with thinning of 
the overlying squamous epithelium. Some 
dilated and irregular vascular channels could 
be seen in the top of the lesions, while the 
other parts were formed by more compact 
cellular proliferation with ill-defined borders 
(Figure 5A). There were typical spindle cells 
of the nodular KS with vascular channels 
formation filled with red blood cells and 
sprinkling chronic inflammation (Figure 
5B). Normally, Kaposi’s cells show slight 
nuclear atypia and very low mitotic count 
(Figure 5C). Immunohistochemical analysis 
showed nuclear positivity for HHV-8 only 
in the neoplastic cells (HHV-8, clone LN53, 
Novus) but not in the surrounding ones 
(Figure 5D).
results
After surgical excision, the relapse oc-
curred on average after 18 months while, 
after laser ablation, it occurred after 14 
months. However, it should be noted that, 
while S.G. (case 1) had relapses close to the 










D. DAKO autostainer, 
15× magnification
tients had new localizations that were far 
from the first ones: penile skin (case 2) and 
perimalleolar area (case 3). Two patients 
were disease-free after 19 and 41 months 
(mean disease free time: 30 months), while 
the last one died from stroke after two years 
from laser ablation, with perimalleolar dis-
ease but no local relapses.
dISCuSSIon
Primary penile Kaposi’s sarcoma is ob-
served in young patients and it is strongly 
associated with HIV infection. In immu-
nocompetent patients it is very rare and, in 
Mediterranean area, it is often present in 
patients in the sixth and seventh decade, 
like our aged patients (mean age = 69 years), 
who were from Southern Italy, and usually 
involves the lower extremities, as patient 
N.F. (case 3) in Figure 3. Penile primary 
KS is very rare in healthy males: in English 
literature, just a few tens of immunocom-
petent patients are described (even if HIV 
or HHV-8 tests are not performed in every 
patient) [3].
What Should the Clinician Ask Him/Herself About the Patient
 y How long has the penile lesion been going on?
 y Is there a history of high-risk sexual intercourses?
 y Are there general symptoms as asthenia, malaise, and mild fever as in HIV patients?
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The pathogenesis of KS is still uncertain, 
but recent data showed a strong correlation 
between all forms of KS and HHV-8 infec-
tions. This virus, discovered in 1994, plays 
a role as a potential oncogenic virus and is 
similar to two other oncogenic herpes vi-
ruses (Saimiri and Epstein-Barr virus) in 
terms of ability to alter the growth of hu-
man endothelial cells in vitro. High HHV-8 
seroprevalence in individuals with high-risk 
sexual activity or HIV-seropositive patients 
denotes the route of sexual transmission, 
while the detection of HHV-8 antibodies 
in children also suggests a non-sexual route: 
saliva could be a potential source of spread 
in general population. Notably, HHV-8 is 
endemic in Sicily [5] and all our patients 
were from Southern Italy (two from Sicily 
and one from Apulia). Moreover, they did 
not claim high-risk sexual activity and had 
few partners before marriage.
Among patients with classic KS, primary 
penile lesions are usually single reddish-
purple to bluish nodules (case 2, Figure 1). 
Multiple papules, nodules (case 3, Figure 
2), plaques, and wart-like or pedunculated 
lesions are less common presentations. The 
most frequently involved site is the glans, 
sometimes in association with swelling and 
lymphatic edema due to massive involve-
ment. Lesions may also involve the foreskin, 
the coronal sulcus, the meatus and, rarely, 
the shaft [6].
Local therapies for KS include simple ex-
cision, cryotherapy, radiation [7], and intra-
lesional therapy. Simple excision is seldom 
used because it is frequently unsatisfactory 
[8]. Cryotherapy is mostly effective for small 
lesions, with 85% of clinical response. On 
the other hand, radiotherapy may be useful 
in large scrotal and penile lesions, but it is a 
time-consuming process [9]. A 50% decrease 
or greater was achieved in 62% of lesions for 
intralesional vincristine [10], 50 to 90% for 
intralesional interferon alpha-2 [11], 56% 
for imiquimod [12]. However, the evidence 
of efficacy of any particular therapy is of low 
quality and does not support recommending 
any particular choice. Ultimately, treatment 
guidelines are lacking for classic Kaposi sar-
coma in English literature [13]. 
Laser therapy is seldom used: in English 
literature only one case was found, dating 
back to 1999 [14]. Carbon dioxide laser has 
not been popular because of the possible 
risk of infectious viral particles in the vapor 
plume. However, our patients have no major 
diseases, particularly they have no evidence 
of HIV infection or immunosuppression, 
and KS forms very-well demarcated intra-
dermal nodules (Figure 5A). This means that 
CO2 laser treatment may be easy, fast, and 
relatively safe. In fact, the procedure was easy 
and effective, with no serious complications 
in every patient, with a complete resolu-
tion of the lesions, leaving good cosmetic 
results after two years from treatment (case 
1, Figure 4). On the other side, there are 
some theoretic drawbacks to laser therapy, 
due to clinical experience, suggesting that 
the real margins of Kaposi’s lesion may be 
quite distant from the macroscopic one and 
that the process of wound healing stimulates 
growth of KS. This could explain late local 
relapses. It is remarkable that in our patients 
they followed surgical excision. Vice versa, 
laser vaporization of excisional borders may 
enlarge and stabilize margins, as in the la-
ser treatment of HPV infection, to prevent 
relapses that normally are not far from the 
primary lesion. In fact, in our opinion, while 
local relapses may show a disease persistence, 
relapses far from the surgical area may be due 
to a new disease.
Owing to the small numbers of patients, 
no definitive cure is yet known for penile KS 
in immunocompetent patients. Moreover no 
follow up schedule is known, even if local 
relapses may occur within two years from 
the diagnosis. Our patients did not show any 
other form of KS (CT scan were negative), 
but some authors claim that a penile unique 
lesion could be the first manifestation of a 
disseminated Kaposi’s sarcoma. Therefore, a 
long follow up is needed, and a gastroscopy 
may be useful. However, our patients did not 
undergo gastroscopy owing to the absence 
of symptoms [15].
In conclusion, primary penile KS is quite 
rare in immunocompetent patients. In every 
case, this disease may be kept in mind when 
treating nonspecific penile lesions. A histo-
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logic evaluation of the lesion may be useful 
for planning the right treatment, its clinical 
staging, and its follow up even if the small 
number of patients doesn’t allow to draw 
conclusions. In fact, there is no treatment 
capable of eradicating HHV-8. However, 
our positive experience shows that it is a 
slowly progressive disease, as observed by 
other Authors [2], that may be cured by lo-
cal therapies, like laser ones.
Key Points
 y Kaposi’s sarcoma is not always linked to HIV infections
 y It may be due to human herpes virus type 8 (HHV-8 ) infection
 y It may be a slowly progressive disease with a good life expectancy
 y It is very rare in immunocompetent patients, however it may be kept in mind when treat-
ing nonspecific penile lesion
 y Owing to its rarity, no definitive guidelines are found in English literature
 y The evidence of effectiveness of any particular intervention is of low quality and does not 
support recommending any diagnostic and/or therapeutic choice
 y CO2 laser therapy might be effective, easy, fast, and safe
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